These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 29962380)
1. Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer. Yang Z; Shen H; He W; Ouyang L; Guo Y; Qian F; Xu B; Xie D; Yang G Tohoku J Exp Med; 2018 Jul; 245(3):141-148. PubMed ID: 29962380 [TBL] [Abstract][Full Text] [Related]
2. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer. Meng Q; Duan P; Li L; Miao Y Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276 [TBL] [Abstract][Full Text] [Related]
3. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer. Ma M; Yu N Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer. Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL Oncotarget; 2015 Sep; 6(29):28491-501. PubMed ID: 26143638 [TBL] [Abstract][Full Text] [Related]
6. Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer. Hou S; Du P; Wang P; Wang C; Liu P; Liu H Clin Transl Oncol; 2017 Sep; 19(9):1107-1116. PubMed ID: 28332091 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer. Lv Q; Sun H; Cao C; Gao B; Qi Y Tumour Biol; 2016 Feb; 37(2):2721-7. PubMed ID: 26408177 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of semaphorin4D, hypoxia-inducible factor-1α and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer. Chen Y; Zhang L; Pan Y; Ren X; Hao Q Int J Mol Sci; 2012 Oct; 13(10):13264-74. PubMed ID: 23202951 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer. Siddiqui GK; Maclean AB; Elmasry K; Wong te Fong A; Morris RW; Rashid M; Begent RH; Boxer GM Angiogenesis; 2011 May; 14(2):155-61. PubMed ID: 21221762 [TBL] [Abstract][Full Text] [Related]
10. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer. Li T; Xue H; Guo Y; Guo K Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179 [TBL] [Abstract][Full Text] [Related]
11. Expression of Gab1 Is Associated with Poor Prognosis of Patients with Epithelial Ovarian Cancer. Hu L; Liu R Tohoku J Exp Med; 2016 Jul; 239(3):177-84. PubMed ID: 27302321 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer. Hou T; Yang C; Tong C; Zhang H; Xiao J; Li J Int J Clin Exp Pathol; 2014; 7(1):280-7. PubMed ID: 24427349 [TBL] [Abstract][Full Text] [Related]
13. Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer. Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL Int J Cancer; 2015 Aug; 137(3):560-70. PubMed ID: 25630587 [TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer. Wang M; He Y; Shi L; Shi C Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer. Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797 [TBL] [Abstract][Full Text] [Related]
16. High expression of KIF14 is associated with poor prognosis in patients with epithelial ovarian cancer. Qiu HL; Deng SZ; Li C; Tian ZN; Song XQ; Yao GD; Geng JS Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):239-245. PubMed ID: 28165566 [TBL] [Abstract][Full Text] [Related]
17. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC). Shuang T; Wang M; Zhou Y; Shi C Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143 [TBL] [Abstract][Full Text] [Related]
18. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer. Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963 [TBL] [Abstract][Full Text] [Related]
19. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival. Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of HOXC8 is Associated With Poor Prognosis in Epithelial Ovarian Cancer. Lu S; Liu R; Su M; Wei Y; Yang S; He S; Wang X; Qiang F; Chen C; Zhao S; Qian L; Shao M; Mao G Reprod Sci; 2016 Jul; 23(7):944-54. PubMed ID: 26763553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]